Anti-PD-1 inhibits Foxp3(+) Treg cell conversion and unleashes intratumoural effector T cells thereby enhancing the efficacy of a cancer vaccine in a mouse model.

Dyck L, Wilk MM, Raverdeau M, Misiak A, Boon L, Mills KH

Open source

DOI
10.1007/s00262-016-1906-6
Published
2016 Dec
Container
Cancer immunology, immunotherapy : CII
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00262-016-1906-6,
  title = {Anti-PD-1 inhibits Foxp3(+) Treg cell conversion and unleashes intratumoural effector T cells thereby enhancing the efficacy of a cancer vaccine in a mouse model.},
  author = {Dyck L and Wilk MM and Raverdeau M and Misiak A and Boon L and Mills KH},
  year = {2016},
  journal = {Cancer immunology, immunotherapy : CII},
  doi = {10.1007/s00262-016-1906-6},
  url = {https://doi.org/10.1007/s00262-016-1906-6}
}

RIS

TY  - JOUR
TI  - Anti-PD-1 inhibits Foxp3(+) Treg cell conversion and unleashes intratumoural effector T cells thereby enhancing the efficacy of a cancer vaccine in a mouse model.
AU  - Dyck L
AU  - Wilk MM
AU  - Raverdeau M
AU  - Misiak A
AU  - Boon L
AU  - Mills KH
PY  - 2016
JO  - Cancer immunology, immunotherapy : CII
DO  - 10.1007/s00262-016-1906-6
UR  - https://doi.org/10.1007/s00262-016-1906-6
ER  - 

APA

L, D., MM, W., M, R., A, M., L, B., & KH, M. (2016). Anti-PD-1 inhibits Foxp3(+) Treg cell conversion and unleashes intratumoural effector T cells thereby enhancing the efficacy of a cancer vaccine in a mouse model.. Cancer immunology, immunotherapy : CII. https://doi.org/10.1007/s00262-016-1906-6

Source records